Medicinova (MNOV) Depreciation & Amortization (CF) (2010 - 2025)
Medicinova's (MNOV) quarterly Depreciation & Amortization (CF) came in at $4555.0 in Q4 2025, down 12.01% year-on-year from $5177.0 in Q4 2024, and down 14.11% on a QoQ basis from $5303.0 in Q3 2025.
Medicinova (MNOV) Depreciation & Amortization (CF) (2010 - 2025) Analysis & Trends
Medicinova (MNOV) has 16 years of Depreciation & Amortization (CF) data on file, last reported at $4555.0 in Q4 2025.
- On a quarterly basis, Depreciation & Amortization (CF) fell 12.01% year-over-year to $4555.0 in Q4 2025; TTM through Dec 2025 was $20099.0, a 4.64% decrease from a year earlier, with the FY2025 full-year figure at $20099.0, down 4.64% from the prior year.
- Depreciation & Amortization (CF) for Q4 2025 stood at $4555.0, down from $5303.0 in the prior quarter.
- Over the last five years, Depreciation & Amortization (CF) for MNOV reached as high as $7168.0 in Q3 2021 and fell as low as $4105.0 in Q1 2023.
- Historically, Depreciation & Amortization (CF) has averaged $5266.4 across 5 years, with a median of $5178.5 in 2024.
- Across the five-year window, Depreciation & Amortization (CF) jumped 37.4% in 2021 and plunged 37.79% in 2022, its largest moves.
- Year by year, Depreciation & Amortization (CF) stood at $6374.0 in 2021, then slumped by 32.05% to $4331.0 in 2022, then advanced by 26.81% to $5492.0 in 2023, then dropped by 5.74% to $5177.0 in 2024, then retreated by 12.01% to $4555.0 in 2025.
- Per Business Quant data, the three most recent Depreciation & Amortization (CF) figures were $4555.0 in Q4 2025, $5303.0 in Q3 2025, and $5064.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 41.14 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 91,781.47 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 55.90 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 123.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.20 Mn |
| 10 | Medicinova | 64.48 Mn | 64.48 Mn | 4,754.00 | 4,555.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4,555.00 |
| Dec 31, 2025 | 4,555.00 |
| Sep 30, 2025 | 5,303.00 |
| Sep 30, 2025 | 5,303.00 |
| Jun 30, 2025 | 5,064.00 |
| Jun 30, 2025 | 5,064.00 |
| Mar 31, 2025 | 5,177.00 |
| Mar 31, 2025 | 5,177.00 |
| Dec 31, 2024 | 5,177.00 |
| Dec 31, 2024 | 5,177.00 |
| Sep 30, 2024 | 5,180.00 |
| Sep 30, 2024 | 5,180.00 |
| Jun 30, 2024 | 5,370.00 |
| Jun 30, 2024 | 5,370.00 |
| Mar 31, 2024 | 5,350.00 |
| Mar 31, 2024 | 5,350.00 |
| Dec 31, 2023 | 5,492.00 |
| Dec 31, 2023 | 5,492.00 |
| Sep 30, 2023 | 5,703.00 |
| Sep 30, 2023 | 5,703.00 |